AuditLine › HHS OIG › Centers for Medicare and Medicaid Services
HHS OIG recommendation 22-A-07-080.02
Refund to the Federal Government $241,533 (Federal share) for claims for top-20 multiple-source physician-administered drugs that were ineligible…
The recommendation, in the publisher's words
Refund to the Federal Government $241,533 (Federal share) for claims for top-20 multiple-source physician-administered drugs that were ineligible for Federal reimbursement.
- Responsible agency
- Centers for Medicare and Medicaid Services
- Issued
- August 10, 2022
- Report
- South Carolina Did Not Always Invoice Rebates to Manufacturers for Physician-Administered Drugs (A-07-21-07003) · find it at HHS OIG
- Kind of report
- Audit
- Agency response
- Concur (as recorded by the publisher)
- Closed
- October 9, 2024 (publisher's date)
- Potential savings
- $241,533 (the publisher's figure; not realised savings)
- Publisher topics
- Financial Stewardship, Prescription Drug
“Open” and “closed” are the publisher's words. AuditLine repeats them with the date it read them. It does not check whether a recommendation was carried out, and a closed recommendation is not proof that a problem was fixed.
Dated history
- Issued by HHS OIG. (publisher's date)
- Closed, with status “Closed Implemented”. (publisher's date)
- First recorded by AuditLine. (start of AuditLine's own history for this record)
Dates marked "publisher's date" come from the publisher's file. AuditLine's own observations begin November 10, 2026 and are added each time the publisher's file changes.
Other recommendations from this report
4 more, of which 0 are open in the publisher's file.
- Refund to the Federal Government $14,281,626 (Federal share) for claims for single-source physician-administered drugs that were ineligible for Federal reimbursement.HHS OIG 22-A-07-080.01 · issued Aug 10, 2022 · closed Oct 9, 2024Closed Implemented
- Work with CMS to determine the unallowable portion of $1,328,195 (Federal share) for other claims for multiple-source physician-administered drugs that may have been ineligible for Federal…HHS OIG 22-A-07-080.03 · issued Aug 10, 2022 · closed Oct 9, 2024Closed Implemented
- Work with CMS to determine and refund the unallowable portion of Federal reimbursement for physician-administered drugs that were not invoiced for rebates after December 31, 2019.HHS OIG 22-A-07-080.04 · issued Aug 10, 2022 · closed Oct 9, 2024Closed Implemented
- Continue to review and strengthen its internal controls to ensure that all physician-administered drugs eligible for rebates are invoiced.HHS OIG 22-A-07-080.05 · issued Aug 10, 2022 · closed Oct 28, 2025Closed Implemented
Source
Open this report in HHS OIG's tracker This publisher's records (CSV)
Official export: https://oig.hhs.gov/recommendations/export-recs/. File read , 4,677 rows,
SHA-256 664fdfb3658ecb72…. HHS OIG's status, response, dates and potential-savings labels are the publisher's own claims.